The Turkish Minister for Health announced that clinical trials of the Coronavac vaccine conducted in Turkey, showed that it had a protection rate of 91.25%. So far, 29 of the participants in the trial have developed COVID-19. The trial needs to continue until a minimum of 40 people have been infected.
If all goes to plan, the first vaccinations might begin on 28 December. Healthcare workers will be the first group to receive vaccine.
Countering Misinformation & Disinformation: Practical Training for Organizations
Practical skills to detect, verify, and respond across an evolving information landscape